iSpecimen (ISPC) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for ISPC stock
iSpecimen Inc. Analysis
ISPC Stock News


Popular stocks:
Suncor Energy
NVIDIA
Micron
Tilray
Broadcom
Energy Transfer
Boeing
QUALCOMM

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Zoetis
ATA Creativity Global
American Tower
Novavax
The York Water
Studio City International Holdings
Cedar Fair
Tattooed Chef
Nielsen Holdings
Calliditas Therapeutics


Financial News

Popular Stocks Analysis

Helpful Highlights
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. ISPC

iSpecimen (ISPC) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 26, 2024 (23:20)

Sector: Healthcare

The share price of iSpecimen Inc. (ISPC) now

Latest session on the 26th of July for
iSpecimen Inc. is negative
Trading Volume: 841826
Open: 0.281 /  High: 0.31 /  Low: 0.276
What analysts predict: $3
52-week High/Low: $1.73 / $0.2

50/200 Day Moving Average: $0.321 / $0.415

This figure corresponds to the Average Price over the previous 50/200 days. For iSpecimen stocks, the 50-day moving average is the resistance level today.

For iSpecimen stocks, the 200-day moving average is the resistance level today.

Are you interested in iSpecimen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the iSpecimen stock price in 2024, 2025, 2026, 2027, 2028. How much will one iSpecimen share be worth in 2024 - 2028?

When should I take profit in iSpecimen stock? When should I record a loss on iSpecimen stock? What are analysts' forecasts for iSpecimen stock? What is the future of iSpecimen stock? We forecast iSpecimen stock performance using neural networks based on historical data on iSpecimen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

iSpecimen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for iSpecimen shares. This happens once a day.


Historical and forecast chart of iSpecimen stock

The chart below shows the historical price of iSpecimen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the iSpecimen stock price can be found in the table below.

Long-term forecasts by years.

iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.

iSpecimen daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 28 0.29 0.29 0.30 4.48
Jul 29 0.30 0.29 0.31 6.95
Jul 30 0.29 0.28 0.29 5.58
Jul 31 0.28 0.27 0.29 7.45
Aug 01 0.28 0.28 0.28 2.73
Aug 02 0.28 0.28 0.29 5.22
Aug 03 0.28 0.27 0.29 5.74
Aug 04 0.28 0.27 0.29 4.93
Aug 05 0.27 0.26 0.28 6.39
Aug 06 0.28 0.27 0.29 6.58
Aug 07 0.28 0.27 0.29 6.91
Aug 08 0.29 0.28 0.30 5.93
Aug 09 0.29 0.28 0.29 3.91
Aug 10 0.30 0.29 0.31 6.84
Aug 11 0.31 0.31 0.32 3.14
Aug 12 0.32 0.31 0.32 3.40
Aug 13 0.32 0.31 0.32 4.71
Aug 14 0.31 0.31 0.32 3.53
Aug 15 0.32 0.31 0.33 5.12
Aug 16 0.31 0.30 0.31 6.19
Aug 17 0.31 0.30 0.32 5.13
Aug 18 0.30 0.29 0.30 3.63
Aug 19 0.31 0.30 0.32 6.16
Aug 20 0.32 0.31 0.33 5.63
Aug 21 0.33 0.31 0.34 7.54
Aug 22 0.34 0.33 0.35 7.44
Aug 23 0.33 0.32 0.33 5.43
Aug 24 0.31 0.30 0.32 6.17
Aug 25 0.30 0.29 0.31 5.93
Aug 26 0.31 0.30 0.31 2.75

iSpecimen Daily Price Targets


iSpecimen Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $0.29.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 4.283%.
Pessimistic target level: 0.29
Optimistic target level: 0.30

iSpecimen Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $0.30.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 6.498%.
Pessimistic target level: 0.29
Optimistic target level: 0.31

iSpecimen Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $0.29.
Negative dynamics for iSpecimen shares will prevail with possible volatility of 5.286%.
Pessimistic target level: 0.28
Optimistic target level: 0.29

iSpecimen Stock Forecast 07-31-2024.

Forecast target price for 07-31-2024: $0.28.
Negative dynamics for iSpecimen shares will prevail with possible volatility of 6.930%.
Pessimistic target level: 0.27
Optimistic target level: 0.29

iSpecimen Stock Forecast 08-01-2024.

Forecast target price for 08-01-2024: $0.28.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 2.662%.
Pessimistic target level: 0.28
Optimistic target level: 0.28

iSpecimen Stock Forecast 08-02-2024.

Forecast target price for 08-02-2024: $0.28.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 4.961%.
Pessimistic target level: 0.28
Optimistic target level: 0.29

ISPC (ISPC) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 0.33 0.31 0.35 12.61
Sep. 0.33 0.29 0.35 15.75
Oct. 0.32 0.29 0.35 19.02
Nov. 0.31 0.28 0.34 17.38
Dec. 0.32 0.30 0.34 12.70
Full forecast for 2024

iSpecimen forecast for this year


iSpecimen Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.326895. Pessimistic: $0.31. Optimistic: $0.35


iSpecimen Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $0.327876. Pessimistic: $0.29. Optimistic: $0.35


iSpecimen Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $0.321974. Pessimistic: $0.29. Optimistic: $0.35


iSpecimen Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $0.307002. Pessimistic: $0.28. Optimistic: $0.34


iSpecimen Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $0.322199. Pessimistic: $0.30. Optimistic: $0.34



iSpecimen (ISPC) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 0.33 0.31 0.37 17.19
Feb 0.37 0.33 0.40 17.16
Mar 0.37 0.35 0.41 14.86
Apr 0.38 0.37 0.41 10.29
May 0.42 0.39 0.46 14.31
Jun 0.38 0.35 0.39 10.58
Jul 0.36 0.34 0.40 14.54
Aug 0.40 0.37 0.44 15.67
Sep 0.46 0.41 0.47 13.96
Oct 0.45 0.42 0.47 10.99
Nov 0.42 0.40 0.44 9.58
Dec 0.43 0.41 0.45 7.46
Full forecast for 2025

iSpecimen (ISPC) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.44 0.40 0.49 19.58
Feb 0.45 0.43 0.47 7.59
Mar 0.44 0.39 0.47 16.77
Apr 0.40 0.36 0.42 12.47
May 0.43 0.40 0.48 16.09
Jun 0.39 0.35 0.41 15.46
Jul 0.40 0.38 0.44 13.77
Aug 0.45 0.41 0.48 14.59
Sep 0.47 0.44 0.52 15.20
Oct 0.48 0.45 0.53 15.22
Nov 0.51 0.46 0.53 12.83
Dec 0.54 0.49 0.61 19.96
Full forecast for 2026

iSpecimen (ISPC) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.53 0.49 0.58 16.03
Feb 0.50 0.46 0.53 13.24
Mar 0.57 0.52 0.62 16.49
Apr 0.62 0.59 0.69 13.64
May 0.66 0.61 0.70 12.01
Jun 0.63 0.60 0.67 10.10
Jul 0.69 0.64 0.73 12.74
Aug 0.73 0.69 0.78 11.19
Sep 0.69 0.65 0.72 10.16
Oct 0.71 0.66 0.80 17.41
Nov 0.70 0.65 0.79 16.94
Dec 0.71 0.65 0.75 13.78
Full forecast for 2027

iSpecimen (ISPC) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 0.73 0.70 0.76 7.66
Feb 0.76 0.70 0.85 17.70
Mar 0.72 0.68 0.75 8.77
Apr 0.69 0.63 0.71 11.53
May 0.74 0.69 0.78 11.83
Jun 0.72 0.66 0.80 17.53
Jul 0.69 0.61 0.76 20.20
Aug 0.78 0.73 0.84 12.86
Sep 0.74 0.70 0.82 14.33
Oct 0.72 0.65 0.79 17.32
Nov 0.62 0.56 0.65 13.40
Dec 0.57 0.54 0.62 13.34
Full forecast for 2028

iSpecimen information and performance

iSpecimen Address

450 BEDFORD STREET, SUITE 1010, LEXINGTON, MA, US

Market Capitalization: 3 634 900 $

Market capitalization of the iSpecimen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ISPC shares in the company outstanding by the market price of one share.

EBITDA: -11 435 033 $

EBITDA of iSpecimen is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.28

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.224
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.141

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.429

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 13075100

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

Aptevo Therapeutics Inc. (APVO)
Protagonist Therapeutics, Inc. (PTGX)
Aurinia Pharmaceuticals Inc. (AUPH)
Vir Biotechnology, Inc. (VIR)
Humana Inc. (HUM)
Pasithea Therapeutics Corp. (KTTA)
Aridis Pharmaceuticals, Inc. (ARDS)
Charles River Laboratories International, Inc. (CRL)
Cardinal Health, Inc. (CAH)
Eargo, Inc. (EAR)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website